Charles Schwab Investment Management Inc Oric Pharmaceuticals, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 410,229 shares of ORIC stock, worth $3.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

410,229

Previous 162,366 152.66%

Holding current value

$3.49 Million

Previous $1.15 Million 266.52%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$7.52 - $11.9 $1.86 Million - $2.95 Million	247,863 Added 152.66%	410,229 $4.2 Million
Q2 2024 Aug 12, 2024	BUY	$6.63 - $12.93 $383,359 - $747,638	57,822 Added 55.31%	162,366 $1.15 Million
Q1 2024 May 08, 2024	SELL	$8.04 - $16.03 $16,538 - $32,973	-2,057 Reduced 1.93%	104,544 $1.44 Million
Q4 2023 Feb 06, 2024	BUY	$5.41 - $9.43 $3,889 - $6,780	719 Added 0.68%	106,601 $980,000
Q2 2023 Aug 09, 2023	BUY	$4.95 - $8.4 $441,683 - $749,523	89,229 Added 535.81%	105,882 $821,000
Q3 2022 Nov 14, 2022	SELL	$3.15 - $5.24 $402,141 - $668,959	-127,664 Reduced 88.46%	16,653 $54,000
Q2 2022 Aug 15, 2022	SELL	$2.7 - $7.07 $192,229 - $503,355	-71,196 Reduced 33.04%	144,317 $647,000
Q1 2022 May 13, 2022	SELL	$4.54 - $16.1 $40,487 - $143,579	-8,918 Reduced 3.97%	215,513 $1.15 Million
Q4 2021 Feb 11, 2022	BUY	$12.01 - $20.3 $57,359 - $96,952	4,776 Added 2.17%	224,431 $3.3 Million
Q3 2021 Nov 16, 2021	BUY	$15.9 - $25.22 $1.41 Million - $2.24 Million	88,840 Added 67.91%	219,655 $4.59 Million
Q2 2021 Aug 16, 2021	BUY	$17.37 - $25.34 $283,339 - $413,346	16,312 Added 14.25%	130,815 $2.32 Million
Q1 2021 May 17, 2021	BUY	$23.67 - $36.85 $113,379 - $176,511	4,790 Added 4.37%	114,503 $2.81 Million
Q4 2020 Feb 16, 2021	BUY	$20.32 - $39.8 $1.15 Million - $2.26 Million	56,837 Added 107.49%	109,713 $3.71 Million
Q3 2020 Nov 13, 2020	SELL	$19.5 - $31.26 $16,497 - $26,445	-846 Reduced 1.57%	52,876 $1.32 Million
Q2 2020 Aug 14, 2020	BUY	$25.68 - $38.12 $1.38 Million - $2.05 Million	53,722 New	53,722 $1.81 Million

Others Institutions Holding ORIC

# of Institutions

124

Shares Held

66.6M

Call Options Held

7.8K

Put Options Held

700

View Full List

About Oric Pharmaceuticals, Inc.

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $336M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

More about ORIC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Oric Pharmaceuticals, Inc. Transaction History